Investor Portal
California Institute for Regenerative Medicine: Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
California Institute for Regenerative Medicine: Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
Jun 24, 2022
The governing Board of the California Institute for Regenerative Medicine (CIRM) announced grant funding to projects in early stage or discovery research, including a $1.2 million award to Tenaya for its gene therapy program targeting heart failure due to prior myocardial infarction.